로딩 중…
지수 로딩 중…
Axsome Therapeutics, Inc.
AXSM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$250.50-0.66%
2026-06-18
Price Chart
Axsome Therapeutics, Inc.+143.46%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $12.89B |
| Revenue | $708M |
| Net Income | $-188M |
| Total Assets | $714M |
| Net Assets | $55M |
| Value | |
| P/B | 236.15x |
| P/S | 18.20x |
| FCF Yield | -0.55% |
| Profitability | |
| ROA | -26.39% |
| Op. Margin | -24.80% |
| Revenue Growth | 57.42% |
| Financial Health | |
| Debt Ratio | 1207.28% |
| Total Debt | $217M |
| FCF | $-71M |
| Cash | $305M |
| Current Ratio | 1.39x |
| Performance | |
| 1Y Return | 143.46% |
| 1M Return | 10.51% |
| From 52W High | -3.72% |
| 1Y MDD | -18.50% |
| Trading | |
| Volume | 711,402 shares |
| Trading Value | $180M |
| Per Share | |
| EPS | $-3.62 |
| BPS | $1.74 |